Published in Hepatitis Weekly, December 23rd, 2002
This could be good news to some patients with diagnoses of hepatocellular carcinoma (HCC) who have no desire to undergo surgery. TACE would provide some HCC patients a viable alternative to surgical resection, according to doctors who coauthored a recent study of HCC patients in Asia, where hepatitis-related cancer is prevalent.
The 2-year study involved 182 HCC patients with adequate liver function and who were deemed eligible for tumor surgery. Investigators...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.